Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates

Conclusion: 18F-MNI-968 has significant potential as a D1R agonist PET radiotracer, and further characterization in human subjects is warranted.

Source: Journal of Nuclear Medicine - September 2, 2021 Category: Nuclear Medicine Authors: Barret, O., Zhang, L., Alagille, D., Constantinescu, C. C., Sandiego, C., Papin, C., Sullivan, J. M., Morley, T., Carroll, V. M., Seibyl, J., Chen, J., Lee, C., Villalobos, A., Gray, D., McCarthy, T. J., Tamagnan, G. Tags: Basic Source Type: research